Epilepsy and bone health in adults (Q35762726)

10 August 2017

1 reference

title

Epilepsy and bone health in adults (English)

1 reference

10 August 2017

Alison M Pack

1

1 reference

PubMed ID

15123008

10 August 2017

Martha J Morrell

series ordinal

2

1 reference

PubMed ID

15123008

10 August 2017

language of work or name

1 reference

1 February 2004

1 reference

10 August 2017

1 reference

10 August 2017

5 Suppl 2

1 reference

10 August 2017

S24-9

1 reference

Disturbance of Calcium Metabolism by Anticonvulsant Drugs

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

The Effect of Anticonvulsant Therapy on Serum Levels of 25-Hydroxy-Vitamin D, Calcium, and Parathyroid Hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Biochemical evidence for osteomalacia with carbamazepine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Anticonvulsant drugs and bone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Serum gamma glutamyl transferase and alkaline phosphatase activities in epileptics receiving anticonvulsant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Effect of antiepileptic drugs on bone density in ambulatory patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Increased bone turnover in epileptic patients treated with carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Osteomalacia with Long-term Anticonvulsant Therapy in Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Antiepileptic drug-induced bone loss in young male patients who have seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Bone density and antiepileptic drugs: a case-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Lifetime occupational physical activity and risk of hip fracture in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Incidence of five common fracture types in an institutional epileptic population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Fracture risk is increased in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Altered Calcium Metabolism in Epileptic Children on Anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Influence of Diphenylhydantoin and Phenobarbital on Intestinal Calcium Transport in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Effect of vitamin D2and D3on bone-mineral content in carbamazepine-treated epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Carbamazepine and bone mineral metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Effect of carbamazepine and valproate on bone mineral density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.11.029

10.1016/J.YEBEH.2003.11.029

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15123008